RxDoctor Payments Data

Gerald Gong, MD

Pediatric Pulmonology · Phoenix, AZNPI 1558323105

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by AbbVie at 34.7% of the total. That places this record below the midpoint for pediatric pulmonology clinicians in AZ, where the typical reported total is $1,072.

$205in general payments, 2019–2025

Across 10 payments — averaging $20.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$71
  • Tactile Systems Technology Inc$46
  • GSK$33
  • Philips North America LLC$21
  • Vapotherm Inc$19
  • PARI Respiratory Equipment, Inc.$15
$2,605in research payments, 2019–2025

Across 7 payments — averaging $372.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vivus LLC$2K
  • AbbVie$1K

What the payments were for

  • Food & beverage$205100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie3$71
Tactile Systems Technology Inc2$46
GSK2$33
Philips North America LLC1$21
Vapotherm Inc1$19
PARI Respiratory Equipment, Inc.1$15

How this compares

$205 in reported general payments places this provider in the 20th percentile of 20 pediatric pulmonology providers in Arizona.

See all pediatric pulmonology providers in Arizona

Medicare billing

Part B allowed, 2024
$4,655
Medicare patients
14
Services billed
60

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrikaftaElexacaftor/Tezacaftor/Ivacaft78$2,069,697
CreonLipase/Protease/Amylase17$82,741
Combivent RespimatIpratropium/Albuterol Sulfate15$6,860
DuleraMometasone/Formoterol19$6,265
Incruse ElliptaUmeclidinium Bromide12$3,990
Albuterol Sulfate HfaAlbuterol Sulfate36$1,236
Azithromycin26$463
Omeprazole14$133
Montelukast Sodium21$127
Pantoprazole Sodium12$96
Prednisone14$39

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon$71$82,74117 claims
GSKIncruse Ellipta$33$3,99012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 20 pediatric pulmonology providers in Arizona.

Other pediatric pulmonology in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →